v3.25.1
Unaudited Condensed Consolidated Statements of Change in Stockholders’ Deficit - USD ($)
Preferred stock
Common stock
Additional paid in capital
Accumulated Deficit
Accumulated other comprehensive loss
Total
Balance at Dec. 31, 2022 $ 74 $ 1,528,926 $ (909,691) $ (1,863) $ 617,446
Balance (in Shares) at Dec. 31, 2022 742,416        
Forgiveness of related party's debt          
Foreign currency translation adjustments 788 788
Net loss (7,338,171) (7,338,171)
Balance at Dec. 31, 2023 $ 74 1,528,926 (8,247,862) (1,075) (6,719,937)
Balance (in Shares) at Dec. 31, 2023 [1] 742,416        
Issuance of shares upon the reverse recapitalization $ 13 (2,833,487) (2,833,474)
Issuance of shares upon the reverse recapitalization (in Shares) 134,476        
Additional shares issued in connection with reverse recapitalization $ 1 (1)
Additional shares issued in connection with reverse recapitalization (in Shares)   5,114        
Stock compensation expense 171,897 171,897
Stock compensation expense (in Shares) 2,091        
Shares to be issued for stock compensation
Shares to be issued for stock compensation (in Shares) (2,091)        
Foreign currency translation adjustments 50 50
Net loss (2,306,806) (2,306,806)
Balance at Mar. 31, 2024 $ 88 1,700,822 (13,388,155) (1,025) (11,688,270)
Balance (in Shares) at Mar. 31, 2024 [1] 882,006        
Balance at Dec. 31, 2023 $ 74 1,528,926 (8,247,862) (1,075) (6,719,937)
Balance (in Shares) at Dec. 31, 2023 [1] 742,416        
Issuance of shares upon the reverse recapitalization $ 13 (2,833,487) (2,833,474)
Issuance of shares upon the reverse recapitalization (in Shares)   134,476        
Additional shares issued in connection with reverse recapitalization $ 1 (1)  
Additional shares issued in connection with reverse recapitalization (in Shares)   5,114        
Stock compensation expense $ 10 1,413,448 1,413,458
Stock compensation expense (in Shares)   101,091        
Shares to be issued for stock compensation $ (8) 8  
Shares to be issued for stock compensation (in Shares)   (82,757)        
Shares and warrants issued through private placement $ 1 58,089 58,090
Shares and warrants issued through private placement (in Shares)   6,000        
Shares and warrants issued through July public offering $ 17 1,003,983 1,004,000
Shares and warrants issued through July public offering (in Shares)   166,667        
Forgiveness of related party's debt 2,135,573 2,135,573
Shares and warrants issued through November public offering $ 84 2,304,869 2,304,953
Shares and warrants issued through November public offering (in Shares)   837,788        
Shares issued through warrants exercises $ 48 261,495 261,543
Shares issued through warrants exercises (in Shares)   477,659        
Shares issued through November Pre-funded warrants exercises $ 6 189,884 189,890
Shares issued through November Pre-funded warrants exercises (in Shares)   56,667        
Shares issued through debt-to-equity conversion $ 57 1,499,943 1,500,000
Shares issued through debt-to-equity conversion (in Shares)   568,182        
Shares to be issued for debt-to-equity conversion $ (57) 57
Shares to be issued for debt-to-equity conversion (in Shares)   (568,182)        
Additional round up shares issued due to 1-for-30 reverse stock split
Additional round up shares issued due to 1-for-30 reverse stock split (in Shares)   243        
Foreign currency translation adjustments 94 94
Net loss (13,653,340) (13,653,340)
Balance at Dec. 31, 2024 $ 246 10,396,274 (24,734,689) (981) (14,339,150)
Balance (in Shares) at Dec. 31, 2024 [1] 2,445,364        
Stock compensation expense $ 8 84,928 84,936
Stock compensation expense (in Shares) 84,091        
Shares to be issued for stock compensation
Shares to be issued for stock compensation (in Shares) (834)        
Shares issued through warrants exercises $ 184 865,239 865,423
Shares issued through warrants exercises (in Shares) 1,839,023        
Shares issued through debt-to-equity conversion $ 57 (57)
Shares issued through debt-to-equity conversion (in Shares) 568,182        
Foreign currency translation adjustments 394 394
Net loss (2,019,811) (2,019,811)
Balance at Mar. 31, 2025 $ 495 $ 11,346,384 $ (26,754,500) $ (587) $ (15,408,208)
Balance (in Shares) at Mar. 31, 2025 [1] 4,935,826        
[1] Giving retroactive effect to reverse recapitalization effected on March 11, 2024 and the 1-for-30 reverse stock split effected on November 21, 2024